Purchase this article with an account.
Elan Aaron Rosenblat, Kelley J Bohm, Michelle Lee, Kimberly C Sippel, Cecilia Nicols, Jessica B Ciralsky; PROSE in the pediatric population. Invest. Ophthalmol. Vis. Sci. 2015;56(7 ):6075.
Download citation file:
© ARVO (1962-2015); The Authors (2016-present)
To evaluate the tolerability and benefit of PROSE in the pediatric population.
Retrospective case series of five pediatric patients who were fit with the PROSE prosthetic device at our institution were reviewed. All patients were fit by an Optometrist who completed the Boston Foundation for Sight Clinical Fellowship in Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE). We analyzed the visual acuity at contact lens fitting, at three months and at the most recent exam (mean= 17 months) as our primary endpoints. All data was analyzed using the Student’s paired t-test.
Eight eyes of 5 subjects, aged 3 to 12 years at initial visit, who underwent fitting with the PROSE prosthetic devices were reviewed. The indication for using the PROSE prosthetic device was severe ocular surface disease which was evident on exam. The average visual acuity (VA) at the initial prose fitting was 0.928 logMAR, 0.783 logMAR at 3 months, and 0.658 logMAR at the most recent visit. Initial versus most recent vision demonstrated a statistically significant improvement (p=0.01). Initial vs. 3 month (p= 0.7) did not show a statistically significant improvement. All patients were succsessfully fit by their second visit and there were no complications assoicated with PROSE use.
The PROSE prosthetic device has been used with success in patients with severe ocular disease. Although pediatric patients are often seen as more difficult to fit, this study demonstrates the viability and utility of using PROSE in the pediatric population.
This PDF is available to Subscribers Only